California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Drugs for diabetes and heart disease, like semaglutide and Ozempic and Wegovy, also help with weight loss. President Biden ...